Search

Search any products, services and so on here.

About 22403 result(s)

Global Adult Calf Serum Market Research Report 2024

  • Mar 20, 24
  • ID: 144065
  • Pages: 98
  • Figures: 229
  • Views: 15
  • From $2,900

Adult Calf Serum, greater than 12 months, is the blood fraction remaining after the natural coagulation of blood, followed by centrifugation to remove any remaining red blood cells. The global Adult Calf Serum market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. According to our research, the global...


Global Adult Bovine Serum Market Research Report 2024

  • Mar 20, 24
  • ID: 144066
  • Pages: 104
  • Figures: 231
  • Views: 12
  • From $2,900

Adult Bovine Serum, greater than 12 months, is the blood fraction remaining after the natural coagulation of blood, followed by centrifugation to remove any remaining red blood cells. The global Adult Bovine Serum market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. According to our research, the gl...


Global Musculoskeletal Disorder Stem Cell Therapy Market Research Report 2024

  • Mar 20, 24
  • ID: 144080
  • Pages: 67
  • Figures: 118
  • Views: 11
  • From $2,900

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. This report studies on the Musculoskeletal Disorder Stem Cell Therapy. The global Musculoskeletal Disorder Stem Cell Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is...


Global Colesevelam Market Research Report 2024

  • Mar 20, 24
  • ID: 143950
  • Pages: 77
  • Figures: 142
  • Views: 15
  • From $2,900

Colesevelam is a bile acid sequestrant administered orally. Colesevelam is used along with diet, weight loss, and exercise to reduce the amount of cholesterol and certain fatty substances in the blood. The global Colesevelam market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market...


Global Ciclesonide Market Research Report 2024

  • Mar 20, 24
  • ID: 143951
  • Pages: 62
  • Figures: 113
  • Views: 13
  • From $2,900

Ciclesonide is a glucocorticoid used to treat asthma and allergic rhinitis. It is marketed under the brand names Alvesco for asthma and Omnaris, Omniair, and Zetonna for hay fever in the US and Canada. The global Ciclesonide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market...


Global Rufinamide Market Research Report 2024

  • Mar 20, 24
  • ID: 143952
  • Pages: 67
  • Figures: 125
  • Views: 15
  • From $2,900

Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other seizure disorders. The global Rufinamide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Rufinamide is estimated t...


Global Certolizumab Pegol Market Research Report 2024

  • Mar 20, 24
  • ID: 143953
  • Pages: 66
  • Figures: 109
  • Views: 16
  • From $2,900

Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. The global Certolizumab Pegol market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Certolizumab...


Global Degarelix Market Research Report 2024

  • Mar 20, 24
  • ID: 143954
  • Pages: 66
  • Figures: 112
  • Views: 15
  • From $2,900

Degarelix (INN) or degarelix acetate (USAN), sold under the brand name Firmagon among others, is a hormonal therapy used in the treatment of prostate cancer. The global Degarelix market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Degarelix is estimated to increase from $...


Global Etravirine Market Research Report 2024

  • Mar 20, 24
  • ID: 143955
  • Pages: 62
  • Figures: 119
  • Views: 8
  • From $2,900

Etravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etravirine. The global Etravirine market was valued at US$ million in 2023 and is anticipated to reach U...


Global Lacosamide Market Research Report 2024

  • Mar 20, 24
  • ID: 143956
  • Pages: 88
  • Figures: 167
  • Views: 8
  • From $2,900

Lacosamide (INN, formerly known as erlosamide, harkeroside, SPM 927, or ADD 234037), is a medication for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. It is marketed under the trade name Vimpat. The global Lacosamide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2...


Our team would be happy to assist you with your queries.

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232